Our Leadership
 Penn State Milton S. Hershey Medical
Center, Penn State College of Medicine and Penn State Children's Hospital is
committed to enhancing the quality of life through improved health, the professional
preparation of those who will serve the health needs of others, and the discovery of
knowledge that will benefit all.
Harold L. Paz, M.D., M.S
Harold L. Paz, M.D. M.S., began his tenure as Penn
State’s Senior Vice President for Health Affairs, Dean of Penn
State College of Medicine, and Chief Executive Officer of Penn
State Milton S. Hershey Medical Center on Monday, April 24,
2006. He is the fifth individual to serve as Dean and CEO of Penn
State’s medical school and teaching hospital since its founding
nearly 40 years ago.
Most recently, Paz served as Dean of the UMDNJ-Robert Wood
Johnson Medical School and CEO of Robert Wood Johnson University
Medical Group (RWJUMG), the multispecialty group practice of the
medical school. As Dean, Dr. Paz was responsible for all
academic, research and clinical activities of the medical
school. In his role as CEO of RWJUMG, Dr. Paz was responsible
for a region-wide integrated physician delivery system that
includes approximately 600 physicians, a dozen ambulatory care
sites and is affiliated with 34 hospitals throughout central and
southern New Jersey.
Dr. Paz received a bachelor of arts degree in biology and
psychology from the University of Rochester, a master of science
in life science engineering from Tufts University and his
medical degree from the University of Rochester School of
Medicine and Dentistry. He did his internship, residency and was
chief medical resident at Northwestern University. He was a
fellow in pulmonary and critical care medicine at Johns Hopkins
Medical School, where he was an Eudowood Fellow. In addition, he
was a post-doctoral fellow in environmental health science at
Johns Hopkins School of Hygiene and Public Health. Board
certified in Internal Medicine and Pulmonary Medicine, Dr. Paz
remains clinically active with a special interest in patients
with sarcoidosis. His research is focused on the epidemiology
and outcomes of septic shock. |
